Thanks for providing. The paper shows that brain atrophy gets muddy as an AD biomarker due to two confounding factors, age and pattern variability. But it's nice to see that the study was done using the data from the ADNI. That initiative is headed by Michael Weiner, the same person who provided the encouraging quote in our Sept 14 PR.
Market Data 
Markets 
AI
